bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2022.09.05.506328

4.1N and SAP97 regulate different phases of AMPA receptor intracellular transport

Bonnet, C.·Charpentier, J.·Retailleau, N.·Choquet, D.·Coussen, F.
View original source ↗Export metadata ↓

Abstract

Changes in the number of synaptic AMPA subtypes of glutamate receptors (AMPAR) underlie many forms of synaptic plasticity. These variations are controlled by a complex interplay between their intracellular transport (IT), export to the plasma membrane, stabilization at synaptic sites, and recycling. The differential molecular mechanisms involved in these various trafficking pathways and their regulation remains partly unknown. We have recently reported the visualization of AMPAR IT in cultured hippocampal neurons and demonstrated its regulation during synaptic plasticity inducing protocols (Hangen, Cordelieres et al., 2018), opening the path to the differential analysis of the mechanisms controlling AMPAR transport and exocytosis. The cytosolic C-terminal (C-ter.) domain of AMPAR GluA1 subunit is specifically associated with cytoplasmic proteins that could be implicated in the regulation of their IT such as 4.1N and SAP97. Here we analyze how interactions between GluA1 and 4.1N or SAP97 regulate IT and exocytosis at the plasma membrane in basal condition and after cLTP induction. We use sh-RNA against 4.1N and SAP97 and specific mutations and deletions of GluA1 C-ter. domain to characterize how these interactions are involved in coupling AMPAR to the transport machinery. The down-regulation of both 4.1N or SAP97 by shRNAs decrease GluA1 containing vesicle number, modify their transport properties and decrease GluA1 export to the PM, indicating their role in GluA1 IT. The total deletion of the C-ter. domain of GluA1 fully suppresses its IT. Disruption of GluA1 binding to 4.1N decreases the number of GluA1 containing transport vesicles, inhibits GluA1 externalization but does not affect the transport properties of the remaining GluA1 containing vesicles. This indicates a role of the 4.1N-GluA1 interaction during exocytosis of the receptor in basal transmission. In contrast, disrupting the binding between SAP97 and GluA1 modifies the basal transport properties of GluA1 containing vesicles and decreases GluA1 export to the plasma membrane. Importantly, disrupting GluA1 interaction with either 4.1N or SAP97 prevents both the cLTP induced increase in the number of GluA1 containing vesicles observed in control and GluA1 externalization. Our results demonstrate that specific interactions between 4.1N or SAP97 with GluA1 have different roles in GluA1 IT and exocytosis. During basal transmission, the binding of 4.1N to GluA1 allows the fusion/fission membrane exocytosis whereas the interaction with SAP97 is essential for GluA1 IT. During cLTP the interaction of 4.1N with GluA1 allows both IT and exocytosis of the receptor in hippocampal cultured neurons. Altogether, our results identify the differential roles of 4.1N and SAP97 in the control of various phases of GluA1 IT.

Source connections

Explore related subjects

neurosciencePreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Bonnet, C., Charpentier, J., Retailleau, N., Choquet, D., Coussen, F.. 2022-09-06. 4.1N and SAP97 regulate different phases of AMPA receptor intracellular transport. https://doi.org/10.1101/2022.09.05.506328

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗
bioRxiv2026

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗
bioRxiv2026

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗